A Chinese biotech has taken up vaccine maker GSKs offer to share its vaccineboosting platform as it works to develop a product that can stop infection from the novel coronavirus. httpsbuff.ly38W5y6NÂ

A Chinese #biotech has taken up vaccine maker GSK’s offer to share its vaccine-boosting platform as it works to develop a product that can stop infection from the novel #coronavirus. https://buff.ly/38W5y6N 

18:00 EST 24 Feb 2020 | STAT

A Chinese #biotech has taken up vaccine maker GSK’s offer to share its vaccine-boosting platform as it works to develop a product that can stop infection from the novel #coronavirus. https://buff.ly/38W5y6N 

More From BioPortfolio on "A Chinese #biotech has taken up vaccine maker GSK’s offer to share its vaccine-boosting platform as it works to develop a product that can stop infection from the novel #coronavirus. https://buff.ly/38W5y6N "